Compare TTK HEALTHCARE with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE DIVIS LABORATORIES TTK HEALTHCARE/
DIVIS LABORATORIES
 
P/E (TTM) x 18.3 32.7 56.0% View Chart
P/BV x 1.5 7.4 19.9% View Chart
Dividend Yield % 1.1 0.6 173.2%  

Financials

 TTK HEALTHCARE   DIVIS LABORATORIES
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
DIVIS LABORATORIES
Mar-18
TTK HEALTHCARE/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,2151,142 106.4%   
Low Rs610533 114.4%   
Sales per share (Unadj.) Rs444.4146.6 303.1%  
Earnings per share (Unadj.) Rs17.233.0 52.2%  
Cash flow per share (Unadj.) Rs27.638.4 71.9%  
Dividends per share (Unadj.) Rs5.0010.00 50.0%  
Dividend yield (eoy) %0.51.2 45.9%  
Book value per share (Unadj.) Rs177.9222.8 79.9%  
Shares outstanding (eoy) m14.13265.47 5.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.15.7 35.9%   
Avg P/E ratio x52.925.3 208.7%  
P/CF ratio (eoy) x33.021.8 151.5%  
Price / Book Value ratio x5.13.8 136.5%  
Dividend payout %29.030.3 95.8%   
Avg Mkt Cap Rs m12,894222,318 5.8%   
No. of employees `0002.310.8 21.5%   
Total wages/salary Rs m1,3074,561 28.7%   
Avg. sales/employee Rs Th2,715.73,616.0 75.1%   
Avg. wages/employee Rs Th565.3423.8 133.4%   
Avg. net profit/employee Rs Th105.4814.9 12.9%   
INCOME DATA
Net Sales Rs m6,27938,915 16.1%  
Other income Rs m781,134 6.8%   
Total revenues Rs m6,35640,049 15.9%   
Gross profit Rs m49612,617 3.9%  
Depreciation Rs m1471,425 10.3%   
Interest Rs m3413 254.1%   
Profit before tax Rs m39312,313 3.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1493,543 4.2%   
Profit after tax Rs m2448,770 2.8%  
Gross profit margin %7.932.4 24.3%  
Effective tax rate %37.928.8 131.8%   
Net profit margin %3.922.5 17.2%  
BALANCE SHEET DATA
Current assets Rs m2,71745,351 6.0%   
Current liabilities Rs m1,5716,507 24.1%   
Net working cap to sales %18.399.8 18.3%  
Current ratio x1.77.0 24.8%  
Inventory Days Days32127 25.4%  
Debtors Days Days4795 49.0%  
Net fixed assets Rs m99121,160 4.7%   
Share capital Rs m141531 26.6%   
"Free" reserves Rs m2,37358,625 4.0%   
Net worth Rs m2,51459,156 4.3%   
Long term debt Rs m30-   
Total assets Rs m4,15867,832 6.1%  
Interest coverage x12.6926.8 1.4%   
Debt to equity ratio x00-  
Sales to assets ratio x1.50.6 263.2%   
Return on assets %6.712.9 51.5%  
Return on equity %9.714.8 65.4%  
Return on capital %16.920.8 81.3%  
Exports to sales %3.60-   
Imports to sales %0.521.8 2.3%   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m318,485 0.4%   
Fx inflow Rs m22532,359 0.7%   
Fx outflow Rs m719,042 0.8%   
Net fx Rs m15423,317 0.7%   
CASH FLOW
From Operations Rs m1737,759 2.2%  
From Investments Rs m97-4,783 -2.0%  
From Financial Activity Rs m-307-3,142 9.8%  
Net Cashflow Rs m-38-166 22.7%  

Share Holding

Indian Promoters % 65.4 52.0 125.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 11.8 31.4%  
FIIs % 5.2 19.0 27.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.2 150.0%  
Shareholders   12,723 31,796 40.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   NATCO PHARMA  PANACEA BIOTECH  GLENMARK PHARMA  ABBOTT INDIA  PLETHICO PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Oil & Gas and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended lower. At the closing bell, the BSE Sensex stood lower by 262 points (down 0.7%).

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 16, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS